HST
57
10
WU
12
2
PSA
53
-7
AMAT
55
2
PRU
62
-2
HCA
66
-2
GOOGL
58
-4
XRAY
23
-8
AVY
54
-6
AN
49
-5
SIG
47
-3
GPC
45
-5
MRK
28
-5
EMC
62
3
STI
12
-5
PNR
62
-7
CVX
40
2
IVZ
58
6
CCI
39
-8
WMB
63
3
HST
57
10
WU
12
2
PSA
53
-7
AMAT
55
2
PRU
62
-2
HCA
66
-2
GOOGL
58
-4
XRAY
23
-8
AVY
54
-6
AN
49
-5
SIG
47
-3
GPC
45
-5
MRK
28
-5
EMC
62
3
STI
12
-5
PNR
62
-7
CVX
40
2
IVZ
58
6
CCI
39
-8
WMB
63
3
Financhill
Back

Alnylam Pharmaceuticals Quote, Financials, Valuation and Earnings

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

ALNY
Alnylam Pharmaceuticals

Last Price:
269.56
Seasonality Move:
4.48%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Tech Innovator Poised for Strategic Buyouts Invest Now

Learn More

Alnylam Pharmaceuticals Price Quote

$269.56
-1.99 (-0.73%)
(Updated: October 3, 2024 at 6:50 PM ET)

Alnylam Pharmaceuticals Key Stats

Sell
25
Alnylam Pharmaceuticals (ALNY) is a Sell
Day range:
$264.84 - $276.50
52-week range:
$141.98 - $287.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.76
P/B ratio:
0%
Volume:
552.8K
Avg. volume:
815.2K
1-year change:
51.74%
Market cap:
$34.9B
Revenue:
$1.8B
EPS:
$-0.6

How Much Does Alnylam Pharmaceuticals Make?

Is Alnylam Pharmaceuticals Growing As A Company?

Alnylam Pharmaceuticals Stock Price Performance

What Is Alnylam Pharmaceuticals 52-Week High & Low?

Alnylam Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Alnylam Pharmaceuticals?

Is Alnylam Pharmaceuticals Cash Flow Positive?

  • What Is ALNY Cash Flow From Operations?
    Cash flow from operations (TTM) is $372.3M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $232.8M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$285.1M

Alnylam Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ALNY return on invested capital is -8.92%
  • What Is Alnylam Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -1.93%
  • What Is ALNY Return On Equity?
    ROE is a measure of profitability and is 0%

Alnylam Pharmaceuticals Earnings Date & Stock Price

Alnylam Pharmaceuticals Competitors

Alnylam Pharmaceuticals Dividend Yield

Alnylam Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 181.07%
Revenue: 107% 48.56%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 285.91
Upside from Last Price: 5.29%

Major Shareholders

  • How many ALNY shares are owned by institutional investors?
    238.3M ALNY shares are owned by institutional investors
  • How many ALNY shares are owned by insiders?
    527.3K ALNY shares are owned by insiders